Published Date: 13 Mar 2023
Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on diagnosing parasomnias!
Late-breaking data from the 2026 ACTRIMS Forum showed that bazedoxifene acetate failed to improve remyelination outcomes in midlife women with relapsing MS, despite a favorable safety profile.
A nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
2.
Trump slashed US cancer research by 31 percent: Senate report
3.
Mental health risk persists years after cancer diagnosis
4.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
5.
Muscular strength and good physical fitness linked to lower risk of death in people with cancer
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
3.
Understanding the Importance of CA125: A Comprehensive Guide
4.
Unlocking Life Expectancy After Subdural Hematoma: A New Hope
5.
Ultimate Guide to Oncology Services in the USA
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation